New McGA Program: Oncology Specialty Pharmacy Workshop
top of page
Search
Recent Posts
See AllRead Bill McGivney's editorial comment in OBR regarding an executive order aiming to address high prescription drug prices: https://obroncology.com/forum-comments/?post_id=487354
By Jon Larsen, JD, MPP, McGA Policy Consultant In August 2018, the Centers for Medicare and Medicaid Services (CMS) rescinded 2012 guidance that prohibited step therapy from applying to Part B drugs c
bottom of page